Skip to main content
. 2015 Dec 19;173(2):357–371. doi: 10.1111/bph.13377

Figure 2.

Figure 2

ATRA protects primary cardiomyocytes against doxorubicin‐induced cell death. (A) ATRA inhibits the doxorubicin‐induced viability loss in primary cardiomyocytes (n = 5). (B) Western blot analysis of apoptosis‐associated proteins (n = 5). (C) Quantitative results of apoptosis‐associated proteins (Bcl‐2, Bcl‐xl, cleaved PARP and cleaved caspase‐3). Quantitative values are computed as the ratios of density of the targeted protein to that of α‐tubulin. Data are expressed as the mean ± SEM and were analysed by anova. *P < 0.05 versus control and ^P < 0.05 versus Dox.